T. Sirisinha

1.1k total citations
9 papers, 176 citations indexed

About

T. Sirisinha is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Pharmacology. According to data from OpenAlex, T. Sirisinha has authored 9 papers receiving a total of 176 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 3 papers in Public Health, Environmental and Occupational Health and 3 papers in Pharmacology. Recurrent topics in T. Sirisinha's work include Cancer survivorship and care (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Palliative Care and End-of-Life Issues (3 papers). T. Sirisinha is often cited by papers focused on Cancer survivorship and care (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Palliative Care and End-of-Life Issues (3 papers). T. Sirisinha collaborates with scholars based in Thailand, Taiwan and Switzerland. T. Sirisinha's co-authors include Ekaphop Sirachainan, V. Ratanatharathorn, Touch Ativitavas, Ravat Panvichian, Monpat Chamnanphon, Wasun Chantratita, Virote Sriuranpong, Daniel T. T. Chua, John Wen-Cheng Chang and Tony Mok and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Quality of Life Research.

In The Last Decade

T. Sirisinha

9 papers receiving 174 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T. Sirisinha Thailand	5	121	50	47	42	21	9	176
Kelsey S. Lau‐Min United States	8	106 0.9×	25 0.5×	38 0.8×	37 0.9×	21 1.0×	23	221
Jan B. Ruit Netherlands	5	145 1.2×	20 0.4×	39 0.8×	23 0.5×	10 0.5×	6	204
Carin A.T.C. Lunenburg Netherlands	9	226 1.9×	109 2.2×	38 0.8×	30 0.7×	50 2.4×	12	358
Alireza Mousavi Jarrahi Iran	4	255 2.1×	12 0.2×	28 0.6×	75 1.8×	17 0.8×	4	408
Anand Mishra India	10	91 0.8×	10 0.2×	35 0.7×	32 0.8×	20 1.0×	53	295
Marianne Samir Makboul Issac Egypt	9	52 0.4×	34 0.7×	58 1.2×	8 0.2×	23 1.1×	16	235
K. Chrystal United Kingdom	7	73 0.6×	11 0.2×	51 1.1×	8 0.2×	19 0.9×	17	249
Amy L. Pasternak United States	10	42 0.3×	96 1.9×	9 0.2×	24 0.6×	73 3.5×	27	212
Phichai Chansriwong Thailand	9	84 0.7×	17 0.3×	38 0.8×	5 0.1×	27 1.3×	25	176
Suzanne Herd United States	2	21 0.2×	74 1.5×	28 0.6×	161 3.8×	37 1.8×	2	226

Countries citing papers authored by T. Sirisinha

Since Specialization

Citations

This map shows the geographic impact of T. Sirisinha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Sirisinha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Sirisinha more than expected).

Fields of papers citing papers by T. Sirisinha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Sirisinha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Sirisinha. The network helps show where T. Sirisinha may publish in the future.

Co-authorship network of co-authors of T. Sirisinha

This figure shows the co-authorship network connecting the top 25 collaborators of T. Sirisinha. A scholar is included among the top collaborators of T. Sirisinha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Sirisinha. T. Sirisinha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Sirachainan, Ekaphop, et al.. (2012). CYP2D6 polymorphisms influence the efficacy of adjuvant tamoxifen in Thai breast cancer patients. SHILAP Revista de lepidopterología. 5. 149–149. 27 indexed citations

Sirachainan, Ekaphop, Monpat Chamnanphon, T. Sirisinha, et al.. (2012). Impact of CYP2D6 Polymorphisms on Tamoxifen Responses of Women with Breast Cancer: A Microarray-based Study in Thailand. Asian Pacific Journal of Cancer Prevention. 13(9). 4549–4553. 35 indexed citations

Mok, Tony, Chun-Ming Tsai, Kenneth W.T. Tsang, et al.. (2011). Efficacy of bevacizumab with cisplatin and gemcitabine in Asian patients with advanced or recurrent non‐squamous non‐small cell lung cancer who have not received prior chemotherapy: A substudy of the Avastin in Lung trial. Asia-Pacific Journal of Clinical Oncology. 7(s2). 4–12. 37 indexed citations

Ativitavas, Touch, et al.. (2011). Cytochrome P450 2D6 polymorphisms of Thai patients with breast cancer and their outcomes of adjuvant tamoxifen.. Journal of Clinical Oncology. 29(15_suppl). e11037–e11037. 4 indexed citations

Chansriwong, Phichai & T. Sirisinha. (2010). Clinical features, management and outcomes of high-grade glioma patients in Ramathibodi Hospital.. PubMed. 93 Suppl 2. S68–73. 3 indexed citations

Sirisinha, T., et al.. (2006). The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): Validation Study of the Thai Version. Quality of Life Research. 15(1). 167–172. 43 indexed citations

Sirisinha, T., et al.. (2006). Phase II study of concurrent chemoradiation with gemcitabine (GEM) in locally advanced squamous cell carcinoma of the head and neck (SCCHN): Preliminary result. Journal of Clinical Oncology. 24(18_suppl). 15519–15519. 1 indexed citations

Sirisinha, T., et al.. (2002). The European Organization for Research and Treatment of Cancer quality of life questionnaire: translation and reliability study of the Thai version.. PubMed. 85(11). 1210–9. 2 indexed citations

Sirisinha, T., et al.. (2001). Quality of life, Functional Assessment of Cancer Therapy-General.. PubMed. 84(10). 1430–42. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact